Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
4,7-DIAMINO-PYRIDO[2,3-D] PYRIMIDINE DERIVATIVE FOR USE AS JAK INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2017/088289
Kind Code:
A1
Abstract:
The present invention relates to a novel compound being a JAK inhibitor. The compound is a compound of formula (I), its pharmaceutically acceptable salt, prodrug, metabolite, isotope derivative, and solvate, or a pharmaceutical composition containing the compound, and can be employed to prevent or treat a Janus kinase(JAK)-related disease or symptom in a human patient or a mammal patient. The present invention also relates to applications of the compound in which the compound is used as a Janus kinase (JAK) inhibitor in medical experiments, pharmaceutical experiments, biological experiments, physiological experiments, biochemical experiments, and the like.

Inventors:
CHEN YILIN (CN)
PENG HONG (CN)
TAO LIN (CN)
ZHAO YAN (CN)
ZHANG XIAOLI (CN)
ZHAO YINYING (CN)
ZOU YANG (CN)
LI YONGHUA (CN)
WANG XIAOXIA (CN)
Application Number:
PCT/CN2016/070339
Publication Date:
June 01, 2017
Filing Date:
January 07, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HELIOEAST PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61K31/52; A61K31/5377; A61P27/02; A61P29/00; A61P35/00; A61P37/02; A61P37/06; A61P37/08; C07D519/00
Domestic Patent References:
WO2012143320A12012-10-26
WO2014145576A22014-09-18
Foreign References:
CN1409712A2003-04-09
CN1305480A2001-07-25
Other References:
LIAO, GAOHONG: "Research and Development of Small Molecule Janus Kinase Inhibitors", PROGRESS IN PHARMACEUTICAL SCIENCES, vol. 38, no. 2, 28 February 2014 (2014-02-28), pages 112 - 119
Attorney, Agent or Firm:
BEIJING EAST IP LTD. (CN)
Download PDF: